<DOC>
	<DOCNO>NCT02472678</DOCNO>
	<brief_summary>Patients neuroendocrine tumor ( NET ) frequently suffer physical well psychosocial complaint . Patients may experience various symptom tumor burden secrete hormone tumor . They also complaint due anti-cancer treatment accompany side effect . Adequate information essential aspect supportive care . Patients need information care remain frequently unnoticed . The aim current study test effectiveness web-based tailored information support system support patient ' information care need . Key feature website patient self-screening physical psychosocial problem , tailor patient education report problem self-referral professional health care . The investigator expect website highly suitable medium provide tailor information support .</brief_summary>
	<brief_title>Web-based Tailored Information Support Patients With Neuroendocrine Tumor</brief_title>
	<detailed_description>Rationale : Patients neuroendocrine tumor ( NET ) frequently suffer physical well psychosocial complaint . Patients may experience various symptom tumor burden secrete hormone tumor . They also complaint due anti-cancer treatment accompany side effect . Adequate information essential aspect supportive care . Patients need information care remain frequently unnoticed . The aim current study test effectiveness web-based tailored information support system support patient ' information care need . Key feature website patient self-screening physical psychosocial problem , tailor patient education report problem self-referral professional health care . The invetigators expect website highly suitable medium provide tailor information support . Objective : This study combine objective investigate whether web-based tailored information support system reduce distress , determine decrease value distress thermometer , and/or improve patient ' perception satisfaction receive information , determine improve score EORTC QLQ-INFO 25 questionnaire , compare patient receive standard care . Secondary aim improvement quality life determine cancer-specific EORTC QLQ-C30 NET-specific EORTC QLQ-GINET21 , empowerment end study ( subscales Construct Empowering Outcomes questionnaire ) investigate patient ' opinion use web-based tailored information support system ( self-constructed questionnaire ; base construct Technology Acceptance Model ( TAM ) questionnaire two self-constructed question ) . Study design : The present study single center randomize , prospective , intervention study efficacy tailor web-based information support system NET patient . After randomization stratification - base time diagnosis till inclusion- control group receive standard care experimental group receive standard care complement use web-based tailored information support system 12 week . Patients ask fill questionnaire baseline 12 week . Patients intervention group ask fill extra questionnaire use web-based tailored information support system . Study population : Diagnosed NET patient treatment Department Medical Oncology University Medical Center Groningen invite participate study . The investigator stratify newly diagnose patient ( diagnose within six month inclusion ) patient diagnose 6 month inclusion</detailed_description>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<criteria>Adult NET patient ( age ≥ 18 year age ) tumor site disease stage . Ability comprehend Dutch ( read write ) . Informed consent provide Estimated life expectancy le 3 month . Patients history another primary malignancy , except radical adequately treated malignancy patient disease free ≥ 3 year Patients participate WINpilot study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>